These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30540604)

  • 21. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mandible changes evaluated by computed tomography following Botulinum Toxin A injections in square-faced patients.
    Chang CS; Bergeron L; Yu CC; Chen PK; Chen YR
    Aesthetic Plast Surg; 2011 Aug; 35(4):452-5. PubMed ID: 21103871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial.
    Bae H; Kim J; Seo KK; Hu KS; Kim ST; Kim HJ
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?
    Park G; Choi YC; Bae JH; Kim ST
    Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.
    Kim NH; Park RH; Park JB
    Plast Reconstr Surg; 2010 Jun; 125(6):1693-1705. PubMed ID: 20517093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Incobotulinum toxin-A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2-year follow-up study.
    Shome D; Vadera S; Shiva Ram M; Kapoor R
    J Cosmet Dermatol; 2020 Aug; 19(8):1892-1899. PubMed ID: 32539203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Ultrasound Evaluation Approach of Lower Facial Structure Before Masseter Muscle Botulinum Toxin Injection.
    Li Z; Chi Y; Chen C; Jin L; Huang J; Long X; Yu N
    Aesthet Surg J; 2023 Mar; 43(4):NP283-NP292. PubMed ID: 36527687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound-Guided Botulinum Neurotoxin Injection for Masseter Hypertrophy Based on the Structural Pattern of Deep Inferior Tendon and Masseteric Contraction.
    Wang YH; Chang SL; Hu S; Huang YL
    Plast Reconstr Surg; 2022 Jul; 150(1):240e-242e. PubMed ID: 35767638
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a second injection of botulinum toxin on lower facial contouring, as evaluated using 3-dimensional laser scanning.
    Lee HH; Kim ST; Lee KJ; Baik HS
    Dermatol Surg; 2015 Apr; 41(4):439-44. PubMed ID: 25775445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
    Nikolis A; Enright KM; Rudolph C; Cotofana S
    J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
    Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions.
    Peng HP; Peng JH
    J Cosmet Dermatol; 2018 Feb; 17(1):33-38. PubMed ID: 29250900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B; Apaydin N; Loukas M; Tubbs RS
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of unilateral idiopathic masseter muscle hypertrophy with botulinum toxin type A.
    Nilesh K; Dharamsi R; Patil P; Mate P
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC
    Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J; Hsu SH; McGee JS
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.